HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Physiological Role of Glutamate Dehydrogenase in Cancer Cells.

Abstract
NH 4 + increased growth rates and final densities of several human metastatic cancer cells. To assess whether glutamate dehydrogenase (GDH) in cancer cells may catalyze the reverse reaction of NH 4 + fixation, its covalent regulation and kinetic parameters were determined under near-physiological conditions. Increased total protein and phosphorylation were attained in NH 4 + -supplemented metastatic cells, but total cell GDH activity was unchanged. Higher V max values for the GDH reverse reaction vs. forward reaction in both isolated hepatoma (HepM) and liver mitochondria [rat liver mitochondria (RLM)] favored an NH 4 + -fixing role. GDH sigmoidal kinetics with NH 4 + , ADP, and leucine fitted to Hill equation showed n H values of 2 to 3. However, the K 0.5 values for NH 4 + were over 20 mM, questioning the physiological relevance of the GDH reverse reaction, because intracellular NH 4 + in tumors is 1 to 5 mM. In contrast, data fitting to the Monod-Wyman-Changeux (MWC) model revealed lower K m values for NH 4 + , of 6 to 12 mM. In silico analysis made with MWC equation, and using physiological concentrations of substrates and modulators, predicted GDH N-fixing activity in cancer cells. Therefore, together with its thermodynamic feasibility, GDH may reach rates for its reverse, NH 4 + -fixing reaction that are compatible with an anabolic role for supporting growth of cancer cells.
AuthorsRafael Moreno-Sánchez, Álvaro Marín-Hernández, Juan C Gallardo-Pérez, Silvia C Pacheco-Velázquez, Diana X Robledo-Cadena, Joaquín Alberto Padilla-Flores, Emma Saavedra, Sara Rodríguez-Enríquez
JournalFrontiers in oncology (Front Oncol) Vol. 10 Pg. 429 ( 2020) ISSN: 2234-943X [Print] Switzerland
PMID32328457 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Moreno-Sánchez, Marín-Hernández, Gallardo-Pérez, Pacheco-Velázquez, Robledo-Cadena, Padilla-Flores, Saavedra and Rodríguez-Enríquez.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: